Home > Rheumatology > EULAR 2021 > EULAR 2021 Highlights Podcast

EULAR 2021 Highlights Podcast

Presented by
Dr Rachel Giles, Medicom
EULAR 2021


In this podcast, Medicom’s correspondent covers 6 presentations held at the European League Against Rheumatism (EULAR 2021), held 2-5 June 2021. The topics discussed are:

  1. The large prospective E3N-EPIC cohort study demonstrated that exposure to passive smoking in childhood and/or adulthood is associated with an increased risk of rheumatoid arthritis (RA).
  2. Faecal microbiota transplantation (FMT) as an add-on therapy to methotrexate was inferior in the treatment of active peripheral psoriatic arthritis (PsA) compared with sham in the proof-of-concept, randomised, placebo-controlled FLORA trial.
  3. The main conclusion of a prospective, longitudinal real-world study among RA patients in the UK demonstrated that remote management provides a feasible alternative for routine outpatient follow-up.
  4. The risk of severe COVID-19 outcomes in patients with rheumatoid arthritis (RA) is 4 times higher for rituximab users and 2 times higher for JAK inhibitor users compared with TNF inhibitor users.
  5. Updates on COVID-19 vaccines in patients with rheumatic disease.
  6. The KEEPsAKE 2 trial showed that risankizumab leads to significantly greater improvements in signs and symptoms than placebo in patients with active psoriatic arthritis (PsA) who have shown inadequate response or intolerance to 1 or 2 biologic therapies or at least one DMARD therapy.


Copyright ©2021 Medicom Medical Publishers

Posted on